4.4 Article

AMYLOID POLYNEUROPATHY CAUSED BY WILD-TYPE TRANSTHYRETIN

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Recent progress in the understanding and treatment of transthyretin amyloidosis

Y. Sekijima

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)

Article Medicine, General & Internal

Repurposing Diflunisal for Familial Amyloid Polyneuropathy A Randomized Clinical Trial

John L. Berk et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Article Medicine, General & Internal

Amyloid Neuropathies

Susan C. Shin et al.

MOUNT SINAI JOURNAL OF MEDICINE (2012)

Meeting Abstract Biochemistry & Molecular Biology

Varied patterns of inaugural light-chain (AL) amyloid polyneuropathy: a monocentric study of 24 patients

D. Adams et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2011)

Article Biochemistry & Molecular Biology

Spinal multifocal amyloidosis derived from wild-type transthyretin

Takanao Sueyoshi et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2011)

Article Pathology

Wild-type transthyretin-derived amyloidosis in various Ligaments and tendons

Takanao Sueyoshi et al.

HUMAN PATHOLOGY (2011)

Review Clinical Neurology

Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP)

V. Plante-Bordeneuve et al.

NEUROLOGY (2007)

Article Clinical Neurology

Amyloid myopathy: Characteristic features of a still underdiagnosed disease

JE Chapin et al.

MUSCLE & NERVE (2005)